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Hair Cortisol as a Biomarker of Stress
in Mindfulness Training for Smokers
Simon B. Goldberg, BA,1,2 Alison R. Manley, BA,3 Stevens S. Smith, PhD,3,4 Jeffrey M. Greeson, PhD,5,6
Evan Russell, MS,7 Stan Van Uum, MD, PhD,8 Gideon Koren, MD,9,10 and James M. Davis, MD3,4
Abstract
Objectives: Stress is a well-known predictor of smoking relapse, and cortisol is a primary biomarker of stress.
The current pilot study examined changes in levels of cortisol in hair within the context of two time-intensity
matched behavioral smoking cessation treatments: mindfulness training for smokers and a cognitive-behavioral
comparison group.
Participants: Eighteen participants were recruited from a larger randomized controlled trial of smoking ces-
sation.
Outcome Measures: Hair samples (3 cm) were obtained 1 month after quit attempt, allowing for a retrospective
analysis of hair cortisol at preintervention and post–quit attempt time periods. Self-reported negative affect was
also assessed before and after treatment.
Intervention: Both groups received a 7-week intensive intervention using mindfulness or cognitive-behavioral
strategies.
Results: Cortisol significantly decreased from baseline to 1 month after quit attempt in the entire sample (d = - 0.35;
p = .005). In subsequent repeated-measures analysis of variance models, time by group and time by quit status
interaction effects were not significant. However, post hoc paired t tests yielded significant pre–post effects
among those randomly assigned to the mindfulness condition (d = - 0.48; p = .018) and in those abstinent at post-test
(d = - 0.41; p = .004). Decreased hair cortisol correlated with reduced negative affect (r = .60; p = .011).
Conclusions: These preliminary findings suggest that smoking cessation intervention is associated with de-
creased hair cortisol levels and that reduced hair cortisol may be specifically associated with mindfulness
training and smoking abstinence. Results support the use of hair cortisol as a novel objective biomarker in
future research.
Introduction
Quitting smoking is notoriously difficult, and highrelapse rates in smokers have encouraged investigation
of physiologic and psychological processes associated with
smoking and smoking cessation. Cortisol is a glucocorticoid
hormone that plays a key regulatory role in the immune,
metabolic, and central nervous systems.1 The hypothalamic-
pituitary-adrenocortical (HPA) axis, which regulates cortisol
secretion, is highly responsive to nicotine.2 Smokers display
higher salivary cortisol levels relative to nonsmokers,3–5 with
cortisol decreasing when smokers quit.4,6,7 Increased cortisol
in smokers is generally believed to be attributable to nicotine
exposure.4
While the effects of smoking on cortisol have been con-
sistent and robust, findings on cortisol as a predictor of
smoking behavior have been less consistent and less intui-
tive. For example, lower levels of absolute salivary cortisol
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and decreases in mean salivary cortisol have been associated
with an increased risk for smoking relapse, increased self-
reported ratings of smoking urges, and increased withdrawal
related distress.6–8 Therefore, researchers have investigated
additional variables that could further explain variability in
smoking cessation outcomes.
Negative affect is a potent risk factor for smoking re-
lapse9 and may form a link between cortisol and smoking. A
substantial body of research supports an affective model of
nicotine dependence, with nicotine use maintained through
negative reinforcement with the expectation that substance
use will alleviate unpleasant feelings.9
Acute and chronic negative affect have been linked to
HPA axis activity.10,11 Chronic stress exposure has been
linked in meta-analysis12 to a flatter diurnal cortisol slope
(Cohen d = 0.39) and a higher daily cortisol output volume
(d = 0.31). Higher cortisol levels have also been associated
with higher ratings of subjective distress13 and rise and fall
in tandem with changes in negative affect.14
Taken together, these findings linking negative affect,
increased risk of smoking relapse, and increased cortisol
output under stress suggest that stress reduction interven-
tions designed to cultivate emotion regulation skills and
target social-emotional processes could conceivably aid
smoking cessation, and may be marked by lower levels of
cortisol.
Historically, cortisol has been assessed through plasma,
saliva, or urine, all of which are reliable methods for ob-
taining real-time estimates of cortisol in the body.12 While
these methods provide valuable insight into short-term
fluctuations in cortisol secretion, their experimental or clin-
ical use presents substantial challenges. Serum and saliva
cortisol are highly responsive to diurnal physiologic pro-
cesses and respond quickly to environmental stressors, yet
these methods are susceptible to technical problems with
sample collection and processing, often leading to substan-
tial missing data. Urinary cortisol provides information on
HPA axis activity over a somewhat longer period of time,
but sample collection is time intensive and provides only
limited information on mean cortisol output over weeks or
months.
Hair cortisol measurement is a novel assessment method
gaining popularity and validity in the past decade.15,16 To
date, hair cortisol correlates highly with other methods of
cortisol measurement in both humans and animals.17,18
Levels have also been shown to change in expected direc-
tions in response to well-characterized stressors such as
peer-raising in macaques19 and the third trimester of human
pregnancy.20 Hair cortisol is also responsive to substance
abuse, with higher hair cortisol levels found in alcohol-
dependent participants during an active drinking phase
compared with abstinent alcohol-dependent participants or
controls.21
Hair cortisol holds substantial promise for measuring
HPA axis activity because sample collection is simple (see
Materials and Methods below). In addition, it is possible to
assess changes over the course of several months in a single
sample,15 thereby reducing vulnerability to missing data.
Hair cortisol may be particularly useful for assessing phe-
nomena involving long-term affective changes, such as
those that might occur in the context of alternative and com-
plementary medicine interventions.
Hair Cortisol in Mindfulness Training for Smokers
The current pilot study sought to examine changes in hair
cortisol in a subsample of smokers participating in a larger
randomized trial of smoking cessation comparing mindfulness
training for smokers22 (MTS) to a cognitive-behavioral therapy
(CBT) active control group. Mindfulness-based interventions
have demonstrated efficacy for reducing stress in both clinical
and nonclinical populations.23 Support exists for applications
of mindfulness to a range of medical and psychological con-
ditions, including substance use disorders.24,25 Evidence for the
impact of mindfulness-based interventions on cortisol, how-
ever, remains mixed.26 For example, Marcus et al.27 reported
significant decreases in the cortisol awakening response in a
sample of 21 individuals receiving Mindfulness-Based Stress
Reduction (MBSR) within residential substance abuse treat-
ment, while others28 failed to detect pre–post differences for
MBSR participants in a self-selected community sample. Dif-
ficulties in salivary cortisol measurement (e.g., diurnal fluctu-
ation) may present a key methodologic barrier to accurate
assessment.26 Hair cortisol assessment may provide an alter-
native method—one less susceptible to the aforementioned
methodologic challenges with cortisol measurement—for in-
dexing HPA axis-relevant physiologic effects.
The current pilot study examined changes in hair cortisol
in a sample of smokers participating in a randomized trial
comparing MTS22,29 to a time-intensity matched CBT
control group. Mindfulness-based interventions have dem-
onstrated efficacy for reducing stress23 and specifically for
the treatment of substance abuse.24,25 Evidence for the use
of cortisol as a useful biomarker in mindfulness-based in-
terventions, however, remains inconclusive.26
The pilot study was designed to answer the following
questions:
Q1. Is participation in a smoking cessation intervention
associated with a decrease in hair cortisol levels?
Q2. Do intervention effects on hair cortisol differ by
treatment type (i.e., mindfulness vs. CBT)?
Q3. Is smoking abstinence following an intervention as-
sociated with decreased hair cortisol levels?




Participants were randomly assigned to receive one of two
time-intensity matched 7-week behavioral smoking cessa-
tion interventions: MTS22 or Freedom from Smoking En-
hanced (FFS-E, based on Freedom from Smoking).30 The
MTS group received mindfulness instruction and the FFS-E
group received relaxation and CBT strategies targeted to
smoking cessation. Both groups had a total of eight meetings,
made quit attempts approximately 1 month after the first
meeting, and received 2 weeks’ worth of nicotine patches.
The institutional review board approved all study procedures
and participants provided informed consent.
Participants
The larger randomized trial included 175 adult smokers;
135 participants elected to be randomly assigned to a high-
intensity intervention (MTS or FFS-E), and 86 attended a
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1-month postquit study visit. To qualify for hair donation for
the cortisol substudy, individuals must have attended five or
more of the eight MTS or FFS-E classes and the 1-month
postquit study visit. On the basis of guidelines from prior
studies,17,31 participants were excluded from hair donation if
they reported using dye or bleach on their hair in the past
year, were younger than age 25 or older than age 65 years,
or were currently using pharmaceutical glucocorticoids.
The hair cortisol substudy sample included 18 individuals
drawn from an eligible pool of 36 who were offered $30 to
donate 3 cm of hair. When compared at baseline to the eli-
gible participants who did not donate hair, the substudy sample
was more likely to be female ( p = .015), smoke fewer cig-
arettes per day ( p = .029), and report lower nicotine de-
pendence on the Fagerström Test for Nicotine Dependence
( p = .025). No other differences were noted between the
substudy sample and the eligible sample.
Measures
Baseline demographic questionnaire. At baseline, all
participants completed a brief questionnaire that assessed
demographic characteristics and smoking history.
Smoking status. Biochemically confirmed 7-day point
prevalence abstinence was assessed. A cutoff of 7.0 parts
per million exhaled carbon monoxide32 was used to confirm
abstinence.
Nicotine dependence. The Fagerström Test for Nicotine
Dependence33 was administered at baseline to assess se-
verity of smoking addiction (a = .60 in the current trial).
Negative affect. The Depression Anxiety Stress Scale34
asks participants to rate negative affect and somatic symp-
toms over the past week. The total score was used in ana-
lyses (a = .95 in the current trial), with higher scores
indicating greater negative affect.
Hair cortisol. A single 3-cm hair sample was obtained
from each participant at the 1-month postquit study visit. On
the basis of previous work,35 the 1-cm segment most
proximal to the scalp was assayed to indicate postquit cor-
tisol output. The second most proximal 1-cm segment, re-
presenting the month before the quit day, was not analyzed.
The third most proximal 1-cm segment was assayed to in-
dicate cortisol output the month before the intervention.
Hair samples were analyzed by following standard pro-
cedures.17 Cortisol concentrations were adjusted to mass to
provide a hair cortisol concentration in picograms of cortisol
per milligram of hair. Intra- and interassay coefficients of
variation were 6.1% and 10.6%, respectively.
Data analysis
Repeated-measures analysis of variance (RMANOVA;
SPSS software, version 18.0; SPSS, Inc., Chicago, Illinois),
independent and paired t-tests, and Pearson correlations
were used. Effect sizes were computed as Cohen36 d using
the post–pre mean difference divided by the pooled standard
deviation.
Results
Demographic characteristics of the study sample included
the following: white, 88.9%; female, 55.6%; education
beyond high school, 77.8%; and average age, 42.2 – 11.4
years. Smoking history variables were as follows: years
smoked, 22.3 – 9.7; cigarettes per day, 14.5 – 5.3; past quit
attempts, 6.0 – 6.7; average Fagerström Test for Nicotine
Dependence score, 3.6 – 1.6. The MTS and FFS-E groups
did not differ at baseline for any tested variable ( p > .10).
Biochemically confirmed 7-day point prevalence smoking
abstinence at 1 month after quitting did not differ by group:
MTS, 80.0%; FFS-E, 62.5% (Pearson’s chi-square [1] = .68;
p = .410).
A significant main effect for time was found in an RMA-
NOVA model with hair cortisol as the outcome and no other
predictors (F[1,17] = 10.43; p = .005; post–pre d = - 0.35).
The main effect for time remained significant in a model that
included group and a time-by-group interaction as predictors
of change in hair cortisol (F[1,16] = 9.70; p = .007), although
the time-by-group interaction was not significant (F[1,16] =
1.40; p = .254). The main effect for time also remained sig-
nificant in a model predicting cortisol with quit status and a
time-by-quit status interaction as predictors (F[1,16] = 6.05;
p = .026), although the time-by-quit status interaction was not
significant (F[1,16] = .92; p = .353).
Paired samples t-tests were used post hoc to examine
within-group change in hair cortisol (Table 1). Cortisol sig-
nificantly decreased in the MTS group (t[9] = 2.89; p = .018;
d = - 0.48) but not the FFS-E group (t[7] = 1.56; p = .162;
d = - 0.22). A significant drop in cortisol was found in the
quit group (t[12] = 3.51; p = .004; d = - 0.41) but not the
relapsed group (t[4] = 0.74; p = .502; d = - 0.20).
One outlier (3 standard deviations below the mean) was
found for change in negative affect and was removed before







level (pg/mg) t-statistic p-Value d-Value
Full sample 18 220.07 – 87.75 190.56 – 80.88 3.23 .005* - 0.35
Quit 13 207.26 – 92.10 172.30 – 77.14 3.51 .004* - 0.41
Relapsed 5 253.38 – 73.20 238.02 – 77.82 0.74 .502 - 0.20
MTS 10 197.68 – 89.83 158.60 – 73.38 2.89 .018** - 0.48
FFS-E 8 248.06 – 81.93 230.51 – 75.38 1.56 .162 - 0.22
Cortisol values are expressed as mean – standard deviation.
*p < .01; **p < .05.
d, Cohen d (1988) computed by using post–pre mean difference divided by pooled standard deviation; MTS, mindfulness training for
smokers; FFS-E, Freedom from Smoking Enhanced.
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analysis. A significant correlation was found between
change in negative affect and change in cortisol (r = .60;
p = .011) (Fig. 1), with larger drops in cortisol associated
with greater decreases in negative affect.
Discussion
This pilot study examined change in hair cortisol within
the context of two high-intensity smoking cessation inter-
ventions. The primary finding was that participation in an
intensive smoking cessation intervention was associated
with reduction in hair cortisol (Q1). In addition, preliminary
evidence suggested that participation in mindfulness train-
ing and smoking cessation itself may each be independently
associated with reduction in hair cortisol (Q2, Q3).
The effect size for the overall drop in cortisol (d = - 0.35)
following participation in a smoking cessation intervention
was small by Cohen’s36 standards. For intervention partic-
ipants who were abstinent at the 1-month postquit study
visit, the magnitude of cortisol decrease was roughly double
(d = - .41) compared with that in participants who had re-
lapsed (d = - .20). This finding supports research showing
that long-term nicotine exposure is associated with in-
creased cortisol output.3–5 A similar difference in magnitude
was observed comparing changes in the MTS (d = - 0.48)
and FFS-E group (d = - 0.22). The large drop in cortisol
seen in the mindfulness condition is consistent with pre-
liminary evidence that mindfulness training (e.g., MBSR)
may reduce cortisol.26
Notably, the nonsignificant RMANOVA interaction terms
suggested no difference in cortisol decrease between groups
(i.e., quit status or treatment assignment). The small overall
sample provided low statistical power to detect interaction
effects, which may explain why significant differences were
observed only with use of paired t tests.
The significant positive correlations in the expected di-
rection between changes in hair cortisol and changes in self-
reported negative affect support the notion that hair cortisol
may be a useful biomarker for psychological stress (Q4).
In conclusion, this pilot study found that participation in
an intensive behavioral treatment for smoking cessation is
associated with decreased hair cortisol. This is meaningful
given that hair sampling provides a measure of long-term
cortisol secretion, not easily ascertained through other means
(i.e., blood or saliva). The additional findings are intriguing
but require replication in a larger sample. Overall, this study
supports hair cortisol as a straightforward, objective bio-
marker for use in future studies, particularly interventions
designed to affect health through changes in stress.
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